Esophageal carcinoma: Surgery, radiotherapy, and chemotherapy

Current Opinion in Gastroenterology

Volumn 18, Issue 4, 2002, Pages 490-495

  Van Lanschot, J Jan B ^a   Aleman, Berthe M P ^a   Richel, Dick J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IRINOTECAN; PACLITAXEL;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; HYPOPHARYNX CARCINOMA; LARYNGECTOMY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; QUALITY OF LIFE; REVIEW; VOICE;

EID: 0036085339     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200207000-00015     Document Type: Review

References (43)

1. Hospital volume and hospital mortality for esophagectomy
2. Ösophaguskarzinom-operative therapie in zentren
3. Optimum treatment strategy for superficial esophageal cancer: Endoscopic mucosal resection versus radical esophagectomy
4. ASCOT: A comprehensive clinical database for gastro-oesophageal cancer surgery
5. One-year survey of carcinoma of the esophagus and stomach in Wales
6. Is esophageal cancer a surgical disease?
7. What is appropriate treatment for carcinoma of the thoracic esophagus?
8. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis
9. Is there a "standard of care" operation for esophageal cancer?
10. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?
11. Curative resection for esophageal adenocarcinoma. Analysis of 100 en bloc esophagectomies
12. Exclusive radical surgery for esophageal adenocarcinoma
13. Transhiatal esophagectomy for treatment of benign and malignant esophageal disease
14. Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma
15. Laparoscopic peritoneal lavage in staging gastric and esophageal cancer
16. Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer?
17. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the esophagus or gastric cardia
18. PET scanning in malignancy: Infant, adolescent or mature citizen?
19. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography
20. Preoperative evaluation of cardiopulmonary reserve with the use of expired gas analysis during exercise testing in patients with squamous cell carcinoma of the thoracic esophagus
21. Analysis of reduced death and complication rates after esophageal resection
22. Diagnosis and management of a mediastinal leak following radical esophagectomy
23. Benign tracheo-neoesophageal fistulas after subtotal esophagectomy
24. Management of thoracic injuries after esophagectomy
25. Surgical management of carcinoma of the hypopharynx and cervical esophagus
26. Current status of surgery for carcinoma of the hypopharynx and cervical esophagus
27. Quality of life in long-term survivors after curative transhiatal esophagectomy for esophageal carcinoma
28. The prognostic value of quality of life scores during treatment for esophageal cancer
29. Other primary cancers occurring after treatment of superficial esophageal cancer
30. Impact of fundus rotation gastroplasty on anastomotic complications after cervical and thoracic esophagogastrostomies: A prospective non-randomised study
31. Denervated stomach as an esophageal substitute recovers intraluminal acidity with time
32. Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus
33. Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas
34. Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma
35. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus
36. Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer
37. Preoperative radiotherapy for esophageal carcinoma
38. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone
39. Does neoadjuvant chemoradiation downstage esophageal carcinoma?
40. N1 esophageal carcinoma: The importance of stage and downstaging
41. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma
42. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction
43. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer